e-learning
resources
Munich 2014
Monday, 08.09.2014
Diagnosis, imaging and surgery for thoracic tumours
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effect of positron emission tomography (PET-CT) on the management of patients with non-small cell lung cancer (NSCLC) prior to oncological treatment
J. Baker, A. Banerjee (Southampton, United Kingdom)
Source:
International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Session:
Diagnosis, imaging and surgery for thoracic tumours
Session type:
Thematic Poster Session
Number:
2773
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Baker, A. Banerjee (Southampton, United Kingdom). The effect of positron emission tomography (PET-CT) on the management of patients with non-small cell lung cancer (NSCLC) prior to oncological treatment. Eur Respir J 2014; 44: Suppl. 58, 2773
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Imaging of eosinophilic lung disease
Related content which might interest you:
Clinical profile and survival of patients undergoing surgery for non-small cell lung cancer: Impact of positron emission tomography adoption
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014
Should preoperative FDG uptake on PET/CT guide postoperative surveillance in surgical non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
Preoperative FDG uptake on PET/CT predicts disease recurrence and survival in early stage non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016
Prognostic value of primary tumour maximum standardized uptake value (SUV max) in non small cell lung cancer (NSCLC) with F18-fluorodeoxyglucose positron emission tomography (FDG-PET): a systematic review and meta-analysis (MA) by the European Lung Cancer
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007
Impact of PET scan on staging and management of lung cancer patients in Indian scenario
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
Incidental findings on PET-CT scans; how they are managed and how they impact on the lung cancer pathway
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Prognostic impact of FDG-PET in recurrence of surgically treated non-small cell lung cancer
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005
Non small cell lung cancer (NSCLC): 42 patients treated with computed tomography (CT) guided percutaneous microwave ablation
Source: International Congress 2015 – A morphological view of chest pathology
Year: 2015
False- positive and false-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in non-small-cell lung cancer
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014
Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Role of mean sUV and metabolic tumor volume by PET/CT for determination of mean survival time in patients with non-small cell lung cancer
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Screening for intracerebral metastasis in radically treated non-small cell lung cancer patients
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
The utility of fluorodeoxyglucose positron emission tomographyin the evaluation of carcinoid tumors presenting as pulmonary nodules. Experience in our hospital
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014
Preoperative evaluation of locally advanced non-small cell lung cancer after induction therapy by positron emission tomography with F-18-fluorodeoxyglucose (FDG-PET)
Source: Eur Respir J 2004; 24: Suppl. 48, 457s
Year: 2004
Algorithm of preoperative N-staging of non-small cell lung cancer
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Should all lung cancer patients requiring pathological nodal staging undergo PET-CT first?
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Surgery for nonsmall cell lung cancer: can improvements be made?
Source: Eur Respir J 2003; 21: 52S-56S
Year: 2003
The visibility of virtual-assisted lung mapping (VAL-MAP) on computed tomography for thoracoscopic lung tumor resection
Source: International Congress 2016 – Current challenges in thoracic surgery
Year: 2016
Should CT-guided biopsy for suspected lung cancer be delayed pending PET/CT results?
Source: International Congress 2016 – Transbronchial diagnostics: from ILD to pheripheral lesions
Year: 2016
The importance of positron emission tomography/computed tomography (PET-CT) to identify distant metastasis in non-small cell lung cancer (NSCLC)
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept